Navigation Links
NHGRI Selects 13 More Organisms for Genome Sequencing

The National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH), announced today that the Large-Scale Sequencing Research Network will target 13 more organisms as part of its ongoing effort to produce genomic data that will expand biological knowledge and improve human health.

The National Advisory Council for Human Genome Research (NACHGR), which is a federally chartered committee that advises NHGRI on program priorities and goals, recently approved a comprehensive plan that adds two new sets of sequencing targets. The strategy includes a mix of whole genome sequencing, genome mapping and sequencing of genomic regions chosen for their scientific merits.

“We want to set the stage for a greater understanding of the major biological innovations that have occurred throughout evolution, with emphasis on learning more about our own genome. Genomic information from a wide array of species already is proving useful in many areas of biomedical research that may benefit both humans and animals,?said Mark S. Guyer, Ph.D., director of NHGRI’s Division of Extramural Research.

The first group of targets consists of nine mammals. Eight mammals will be sequenced at low-density draft coverage, created by sequencing their genomes two times over. This sequencing strategy, begun last year on another set of mammals, is used primarily to identify features that are similar, or conserved, among the genomes of the human and other mammals. Sequences that have been conserved throughout evolution often reveal important functional regions of the human genome. Initial data show that using low-density sequencing for such comparisons is almost as effective as more costly, high-density sequencing. The eight mammals are: 13-lined ground squirrel (Spermophilis tridecemlineatus), megabat (Cynopterus species), microbat (Microchiroptera species), tree shrew (Tupaia belangeri), bushbaby (Otolemur garnetti), hyrax (Procavia capensis), pangolin (
'"/>

Source:NIH


Page: 1 2 3 4 5

Related biology news :

1. NHGRI targets 12 more organisms for genome sequencing
2. NHGRI expands effort to revolutionize sequencing technologies
3. NHGRI announces new sequencing targets
4. NHGRI announces latest sequencing targets
5. NHGRI aims to make DNA sequencing faster, more cost effective
6. Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer
7. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
8. Genome-wide mouse study yields link to human leukemia
9. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
10. Multiple Campylobacter Genomes Sequenced
11. Analysis Of Human Genome To Predict The Development Of Illnesses

Post Your Comments:
(Date:11/23/2009)...in German . , A bit of imagination on the p...ing. It could help to add data from areas where th...t do so constructively. In order to infer missing ... just imagination, physicists at the Max Planck In...of spatial perception called information field the...
(Date:11/23/2009)...in German . , Not just birds, but also a fe...Researchers at Princeton University in the U.S. an...adolfzell, Germany studied the migratory behaviour...ed "Vespertilionidae" with the help of mathematica...short as well as long distances of various kinds o...
(Date:11/22/2009)...sed prenatally to tobacco smoke and during childho... according to research done at Cincinnati Children...s that up to 35 percent of ADHD cases in children ...liminating both of these environmental exposures. ..., "Tobacco and lead exposure each have their own...
Breaking Biology News(10 mins):Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4We're off then: The evolution of bat migration 2Exposure to lead, tobacco smoke raises risk of ADHD 2AFFiRiS AG 3A Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimers Vaccine Candidate AD02 into Clinical Phase II Testing 14915 1AFFiRiS AG 3A Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimers Vaccine Candidate AD02 into Clinical Phase II Testing 14915 2AFFiRiS AG 3A Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimers Vaccine Candidate AD02 into Clinical Phase II Testing 14915 3Morehead Presents Webinar on 26quot 3BHow Physician Attitudes Impact Hospital Goals 26quot 3B 61678 1Morehead Presents Webinar on 26quot 3BHow Physician Attitudes Impact Hospital Goals 26quot 3B 61678 2AAHSA Statement on Senate Health Reform Bill 61676 1AAHSA Statement on Senate Health Reform Bill 61676 2
...mplications for understanding kidney disorders, ge...hiladelphia have identified a second gene that giv...tal disease that affects multiple organs. The Chil...st gene associated with this disease. , The resea...e linked to kidney abnormalities in patients and f...
...sed by arterial blockages related to diabetes, smo...re occurring at an alarming rate. Yet physicians m...may be preventable, according to the International...isfiguring and life-threatening, but are more dang...hich is the reestablishment of blood supply. Diabe...
...hed the findings of a team of scientists at the no... provides a whole genome analysis of the protein k...sm known as Dictyostelium. , Led by Dr. Janet Sm... evolution of kinases, which are enzymes involved ...% of human genes code for protein kinases, and mut...
Other Biology News:Gene discovery may shed light on kidney disease 2Epidemic of unneeded amputations 2Scientists elucidate the kinome of key model organism 2
(Date:11/23/2009)...,, SEATTLE,Nov.23/PRNewswire/--ImmuneDesignC or...nedIDCasExecutiveChairman.Dr.Carterhasasuccessfult...asthef or merChiefExecutiveOfficeratZymoGenetics,i...k,Copenhagen,Denmark. ,, (Photo: http://www.new...StevenReed,IDC,sfounderandChiefExecutiveOfficercom...
(Date:11/20/2009)..., , , , , , , , , ... , , AUDIO: , A team of scientis...iversity of Arizona, Cold Spring Harbor Laboratory... the DNA of corn. The... , , Clic... , , , , , , , ,...
(Date:11/20/2009)..., , STOCKHOLM, November 20 /PRNewswir...at the European Investment Fund (EIF) has entered ...he co-investment fund will be,managed by Karolinsk...portfolio of early-stage pharmaceutical and medica...6.7 M Euros in the co-investment fund. The agreeme...
(Date:11/19/2009)..., , COPENHAGEN, Nov. 19 Danish...bicon cellulosic ethanol plant in Kalundborg, Denm...e of the world,s first and largest 2nd generation ...cellerase enzymes are used in the plant,s innovati... a Division of Danisco, was the first to market wi...
Breaking Biology Technology:Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
...NGELES, March 17 Signalife, Inc. (Amex:,SGN - New...veral formal,purchase and financial commitments wi...logy licenses, devices and services. These commitm..., other parts of Asia and Europe,as well as domest...d CEO, stated: "I anticipate,closing these transac...
...OUIS, March 17 (Nasdaq: SIAL ) -- Sigma-,Aldrich...ng its 2008 Annual,Business Review on Wednesday, M...y Center located at 2909 Laclede, St. Louis, Mo. 6...onclude by 12:30 p.m. CDT,and will also be webcast...ma-aldrich.com ., About Sigma-Aldrich: Sigma-Aldr...
...xpands Development and Support of National Electro...System, EL SEGUNDO, Calif., March 17 Computer,Sc...hat it has been awarded a,task order from the Cent...ntinue developing and supporting the National Elec...stem (NBS). The system helps the CDC,manage and en...
Other Biology Technology:Signalife Sees Accretive Purchase and Financial Commitments 2CSC Continues Support of Centers for Disease Control and Prevention Through New Task Order 2
CD14 MicroBeads, non-human primate from Miltenyi Biotec
...orm, 220 V, is used for agitation and mixing appli...tures, staining and destaining of gels and blots, ...riable speed control (8-40 rpm) and can handle a m... two 29 x 21 cm platforms covered with nonslip rub...
Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals
CD43 MicroBeads, rat from Miltenyi Biotec
Biology Products: